Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Day One Biopharmaceuticals (DAWN) Leases (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Leases for 4 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • Quarterly Leases fell 3.3% to $2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Dec 2025, down 3.3% year-over-year, with the annual reading at $2.3 million for FY2025, 3.3% down from the prior year.
  • Leases for Q4 2025 was $2.3 million at Day One Biopharmaceuticals, down from $2.4 million in the prior quarter.
  • The five-year high for Leases was $2.6 million in Q1 2025, with the low at $164000.0 in Q2 2024.
  • Average Leases over 4 years is $1.2 million, with a median of $781500.0 recorded in 2022.
  • The sharpest move saw Leases plummeted 69.06% in 2024, then soared 1423.78% in 2025.
  • Over 4 years, Leases stood at $699000.0 in 2022, then crashed by 49.64% to $352000.0 in 2023, then surged by 588.07% to $2.4 million in 2024, then fell by 3.3% to $2.3 million in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $2.3 million, $2.4 million, and $2.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.